Patents by Inventor Camillo del Cistia Andrade

Camillo del Cistia Andrade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132565
    Abstract: Disclosed is a method for producing hybrid or non-hybrid recombinant glycoprotein hormones, for example the recombinant equine chorionic gonadotropin (r-eCG), the hybrid recombinant chorionic gonadotropin, the recombinant thyroid-stimulating hormone (r-TSH), the recombinant luteinizing hormone (r-LH), the luteinizing hormone and the recombinant follicle-stimulating hormone (r-FSH). In addition, the present disclosure relates to the recombinant glycoprotein hormones comprising the equine ? and ? subunits, inter alia, the ? subunit of mammals and equine ? subunit, where the two subunits are fused in a simple chain, and chain-modifying agents, which hormones are easier to purify, more homogeneous, easier to produce on an industrial scale without using animals, in comparison with the wild glycoprotein hormone.
    Type: Application
    Filed: September 28, 2023
    Publication date: April 25, 2024
    Inventors: Marcelo Dias BARUFFI, Camillo del Cistia ANDRADE, Rubens Eduardo da SILVA, Robinson Antonio Martins de OLIVEIRA, Daniel Roberto CALLEJON
  • Publication number: 20220267401
    Abstract: Disclosed is a method for producing hybrid or non-hybrid recombinant glycoprotein hormones, for example the recombinant equine chorionic gonadotropin (r-eCG), the hybrid recombinant chorionic gonadotropin, the recombinant thyroid-stimulating hormone (r-TSH), the recombinant luteinising hormone (r-LH), the luteinising hormone and the recombinant follicle-stimulating hormone (r-FSH).
    Type: Application
    Filed: May 10, 2016
    Publication date: August 25, 2022
    Inventors: Marcelo Dias BARUFFI, Camillo del Cistia ANDRADE, Rubens Eduardo da SILVA, Robinson Antonio Martins de OLIVEIRA, Daniel Roberto CALLEJON
  • Patent number: 9637533
    Abstract: The present invention relates to a method for increasing embryo implantation rate in mother's uterus in mammals by administering to the uterus of a mammal an effective amount of beta-galactoside-binding lectin or derivatives thereof, as well as to a product comprising said lectin.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: May 2, 2017
    Assignees: UNIVERSIDADE DE SÃO PAULO-USP, INPRENHA BIOTECHNOLOGIA E DESENVOLVIMENTO AVANçADO LTDA-ME
    Inventors: Marcelo Dias Baruffi, Erika da Silva Carvalho Morani, Marcelo Roncoletta, Camillo del Cistia Andrade, Lilian Cataldi Rodrigues
  • Publication number: 20140057858
    Abstract: The present invention relates to a method for increasing embryo implantation rate in mother's uterus in mammals by administering to the uterus of a mammal an effective amount of beta-galactoside-binding lectin or derivatives thereof, as well as to a product comprising said lectin.
    Type: Application
    Filed: December 9, 2011
    Publication date: February 27, 2014
    Applicants: Inprenha Biotecnologia e Desenvolvimento Avancado Ltda-ME, UNIVERSIDADE DE SAO PAULO - USP
    Inventors: Marcelo Dias Baruffi, Erika da Silva Carvalho Morani, Marcelo Roncoletta, Camillo del Cistia Andrade, Lilian Cataldi Rodrigues